Neuphoria Therapeutics

Scancell heads to Nasdaq via reverse merger with Neuphoria

Scancell and Neuphoria have agreed to a reverse merger that will result in a Nasdaq listing for Scancell and a resolution for Neuphoria’s shareholders.

Will Maddox Jul 23, 2026 10:13am